Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
Nutriband filed a new non-provisional utility patent application with the USPTO covering improved aversive formulations and coating methods for its AVERSA abuse-deterrent transdermal technology. If granted, the application could extend worldwide PCT patent protection for AVERSA-based products, including the lead abuse-deterrent fentanyl patch, to 2046 given the 20-year statutory term from filing.
Key figures
- Patent term years
- 20
- Patent countries issued
- 46
- Potential patent extension year
- 2046
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.